BRPI0515040A - testosterone gels comprising propylene glycol as a penetration enhancer - Google Patents

testosterone gels comprising propylene glycol as a penetration enhancer

Info

Publication number
BRPI0515040A
BRPI0515040A BRPI0515040-0A BRPI0515040A BRPI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A
Authority
BR
Brazil
Prior art keywords
propylene glycol
penetration enhancer
testosterone gels
testosterone
gels
Prior art date
Application number
BRPI0515040-0A
Other languages
Portuguese (pt)
Inventor
Dominique Salin-Drouin
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292170A external-priority patent/EP1634583A1/en
Application filed by Besins Int Lab filed Critical Besins Int Lab
Publication of BRPI0515040A publication Critical patent/BRPI0515040A/en
Publication of BRPI0515040B1 publication Critical patent/BRPI0515040B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

GéIS DE TESTOSTERONA COMPREENDENDO PROPILENO GLICOL COMO FACILITADOR DE PENETRAçãO. A presente invenção refere-se a géis composições farmacêuticas contendo testosterona, e a métodos que utilizam os mesmos.TESTOSTERONE GELS UNDERSTANDING PROPYLENE GLYCOL AS A PENETRATION FACILITATOR. The present invention relates to gels, testosterone-containing pharmaceutical compositions, and methods using them.

BRPI0515040-0A 2004-09-09 2005-09-07 TESTOSTERONE GELS INCLUDING PROPYLENE GLYCOL AS A PENETRATION Enhancer BRPI0515040B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04292170.0 2004-09-09
EP04292170A EP1634583A1 (en) 2004-09-09 2004-09-09 Testosterone gels comprising propylene glycol as penetration enhancer
US63836004P 2004-12-23 2004-12-23
US60/638,360 2004-12-23
PCT/EP2005/010293 WO2006027278A1 (en) 2004-09-09 2005-09-07 Testosterone gels comprising propylene glycol as penetration enhancer

Publications (2)

Publication Number Publication Date
BRPI0515040A true BRPI0515040A (en) 2008-07-01
BRPI0515040B1 BRPI0515040B1 (en) 2021-10-13

Family

ID=39381985

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515040-0A BRPI0515040B1 (en) 2004-09-09 2005-09-07 TESTOSTERONE GELS INCLUDING PROPYLENE GLYCOL AS A PENETRATION Enhancer

Country Status (7)

Country Link
JP (1) JP2008512425A (en)
BR (1) BRPI0515040B1 (en)
EA (1) EA013430B1 (en)
HK (1) HK1099887A1 (en)
IL (1) IL181583A0 (en)
MX (1) MX2007002814A (en)
NZ (1) NZ553446A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
RU2699674C1 (en) * 2015-09-30 2019-09-09 Фуджифилм Корпорэйшн Percutaneous absorption composition
EP3705123A4 (en) * 2017-10-30 2021-08-04 Teikoku Seiyaku Co., Ltd. Transdermally administrable preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0399432B1 (en) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
CZ20031761A3 (en) * 2000-12-22 2004-01-14 Dr. August Wolff Gmbh & Co. Gel composition containing steroid and intended for treating hypogonadism
DE60139625D1 (en) * 2001-12-07 2009-10-01 Besins Int Belgique Gel or solution containing dihydrotestosterones, their method of preparation and use
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition

Also Published As

Publication number Publication date
EA013430B1 (en) 2010-04-30
BRPI0515040B1 (en) 2021-10-13
MX2007002814A (en) 2007-05-16
NZ553446A (en) 2010-05-28
HK1099887A1 (en) 2007-08-24
JP2008512425A (en) 2008-04-24
IL181583A0 (en) 2007-07-04
EA200700580A1 (en) 2007-08-31

Similar Documents

Publication Publication Date Title
UA87158C2 (en) Testosterone gels CONTAINING propylene glycol as penetration enhancer
BRPI0917017B8 (en) s-nitrosoglutathione reductase pyrrole inhibitors as therapeutic agents
BRPI0914682B8 (en) heteroaryl compounds and compositions comprising said compounds
CR11427A (en) 2-FLUORO-2 - DEOXITETRAHYDROURIDINS AS INHIBITORS OF CITIDINE DESAMINASE
UY29112A1 (en) DERIVATIVES OF CONDENSED PIRAZOL, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION
CL2008002319A1 (en) Compounds derived from pyrrolopyrimidine; pharmaceutical composition comprising said compounds; and its use to treat cancer.
CL2007000311A1 (en) Compounds derived from chromen-2-one; pharmaceutical composition that includes them; and their use in the treatment of a proliferative disorder such as cancer.
BR112016015105A2 (en) VAR2CSA-DRUG CONJUGATES
EA200702550A1 (en) METHOD OF OBTAINING EPOXIDE
CR9253A (en) HER ANTIBODY DOSAGE SETTING
ECSP088633A (en) MODIFIED LISINE MIMETIC COMPOUNDS
CR9949A (en) 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITORS (FLAP)
BRPI0617294B8 (en) pharmaceutical composition in hydroalcoholic gel and use of testosterone
ECSP11011054A (en) THERAPEUTIC ANTIVIRAL PEPTIDES
AR054937A1 (en) BIODEGRADABLE GUM
BR122018009866B8 (en) methods for preparing aminocyclohexyl ether compounds and intermediate compounds
BRPI0506888A (en) liquid supplement compositions comprising one or more medicaments
ATE510822T1 (en) POTASSIUM CHANNEL INHIBITORS
ECSP088745A (en) SUBSTITUTED DERIVATIVES OF CHROMANOL AND ITS USE
UY28917A1 (en) DERIVATIVES OF TETRAHYDROISOQUINOLILSULFONAMIDS PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USE
PA8604401A1 (en) ARIL-HETEROAROMATIC PRODUCTS, COMPOSITIONS THAT CONTAIN THEM AND ITS USE.
CR20120544A (en) FUNGICIDE BLENDS I UNDERSTANDING QUINAZOLINAS
CL2008001048A1 (en) COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND AS ANTIBACTERIALS.
GT200600121A (en) NEWS DERIVED FROM TRIAZOLOPIRIMIDINE
MA32321B1 (en) Brin-4-en-21, 17-lactone substituted in the c-ring and the pharmaceutical preparations it contains

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU)

B25G Requested change of headquarter approved

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.